GSK measles vaccine gets U.S. FDA approval FDA/Regulatory, R&D, Therapeutics GSK said on Monday the British drugmaker’s vaccine Priorix was approved by the U.S. Food and Drug Administration for the prevention of measles, mumps and rubella (MMR) in those aged 1 year and above. Read more June 6, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/01/GSK-Vir-ramping-up-U.S.-output-of-COVID-antibody-drug-Reuters-1-21-22.jpg 503 960 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-06-06 03:21:562022-06-06 11:29:47GSK measles vaccine gets U.S. FDA approval
